Buda Juice, Inc. filed a Form 10-Q with the SEC on November 13, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, its first filing period following an initial public offering completed earlier in the year.

Key Highlights

  • Nine-month net sales: The company reported net sales of $13,223 thousand for the nine months ended September 30, 2026, up from $9,714 thousand in the same period of 2025, according to the filing.
  • Nine-month net income: Net income for the nine months ended September 30, 2026 was $1,724 thousand, compared with $2,858 thousand in the prior-year period, the filing disclosed.
  • Third-quarter net income: Net income for the three months ended September 30, 2026 was $866 thousand, versus $881 thousand in the same quarter of 2025.
  • Total assets increased: Total assets as of September 30, 2026 were $24,999 thousand, compared with $4,970 thousand as of December 31, 2025, with cash and cash equivalents rising to $19,277 thousand from $1,840 thousand.
  • IPO proceeds recorded: The company disclosed issuance of common stock in its initial public offering generating $20,816 thousand and an additional $3,000 thousand from the underwriters' over-allotment option exercise, with total offering costs of $3,165 thousand.
  • Shares outstanding: As of November 12, 2026, there were 12,589,602 shares of common stock outstanding, the filing stated.

Buda Juice Financial Results and IPO Impact for the September 2026 Quarter

Buda Juice, Inc. (NYSE American:BUDA), a Delaware-incorporated company headquartered in Dallas, Texas, submitted its quarterly report covering the period ended September 30, 2026. The filing describes the company as a smaller reporting company and an emerging growth company. For the nine months ended September 30, 2026, the company reported net sales of $13,223 thousand and gross profit of $5,161 thousand, compared with net sales of $9,714 thousand and gross profit of $4,413 thousand for the same period in 2025, according to the filing.

Total operating expenses for the nine-month period rose to $3,128 thousand from $1,596 thousand in the prior-year period, driven in part by selling, general and administrative expense increasing to $2,643 thousand from $1,183 thousand, the filing disclosed. Income from operations for the nine months ended September 30, 2026 was $2,033 thousand, versus $2,817 thousand in the comparable 2025 period. Income tax expense for the nine months was $762 thousand, compared with $28 thousand in the prior year, which the filing attributes in part to a deferred income tax liability of $118 thousand recorded as of September 30, 2026.

The balance sheet reflects the company's transition from a members' equity structure to a corporate stockholder structure following its IPO. As of September 30, 2026, total stockholders' equity was $22,891 thousand, up from $3,738 thousand as of December 31, 2025. The equity statement shows the company issued 2,666,667 shares in its IPO and 399,999 shares under the underwriters' over-allotment option during the first quarter of 2026. Treasury stock of $(3,578) thousand was recorded, reflecting a redemption of common stock in connection with the IPO, and stock-based compensation related to RSUs totaled $450 thousand for the nine-month period, per the filing.

What Was Disclosed

Buda Juice, Inc. disclosed nine-month and third-quarter unaudited financial results for the period ended September 30, 2026, including details on its IPO capital raises, a significant increase in total assets, and the company's first income tax obligations following its corporate conversion.